Systemic biomarkers of microvascular alterations in type 1 diabetes associated neuropathy and nephropathy - A prospective long-term follow-up study

Novel Biomarkers of Diabetic Kidney Disease

(2023) Jorge Rico-Fontalvo et al.   Biomolecules

Cut loose TIMP-1: an emerging cytokine in inflammation

(2022) Benjamin Schoeps et al.   TRENDS IN CELL BIOLOGY

Lipocalin 2—not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials

(2022) Sumaira Asaf et al.   IMMUNOLOGIC RESEARCH

Recent Advances in Biomarkers and Regenerative Medicine for Diabetic Neuropathy

(2021) Yoshikai Fujita et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Plasma levels of tissue inhibitor of metalloproteinase-1 in patients with type 1 diabetes mellitus associate with early diabetic neuropathy and nephropathy

(2021) Nektaria Papadopoulou-Marketou et al.   Diabetes & Vascular Disease Research

Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease

(2021) Gaukhar Baidildinova et al.   Frontiers in Cardiovascular Medicine

MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade

(2020) José María Mora-Gutiérrez et al.   Scientific Reports

Matrix Metalloproteinases in Diabetic Kidney Disease

(2020) Garcia-Fernandez et al.   Journal of Clinical Medicine

Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes

(2020) Aleksandra Gasecka et al.   Journal of Clinical Medicine

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases

(2020) Griselda A Cabral-Pacheco et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Angiogenic abnormalities in diabetes mellitus: mechanistic and clinical aspects

(2019) Gian Paolo Fadini et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy

(2018) Zohaib Iqbal et al.   CLINICAL THERAPEUTICS

Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis

(2016) Nektaria Papadopoulou-Marketou et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Inflammation in childhood type 1 diabetes; influence of glycemic control

(2015) Martin Heier et al.   ATHEROSCLEROSIS

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

(2015) Stijn A Peeters et al.   Cardiovascular Diabetology

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

(2014) Katherine R. Tuttle et al.   DIABETES CARE

Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain

(2014) Anurag Kuhad et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Early Electrophysiological Abnormalities and Clinical Neuropathy: A prospective study in patients with type 1 diabetes

(2013) L. Hyllienmark et al.   DIABETES CARE

Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences

(2012) Aldo Clerico et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Relations of Biomarkers of Extracellular Matrix Remodeling to Incident Cardiovascular Events and Mortality

(2010) Raghava S. Velagaleti et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

(2010) S. Tesfaye et al.   DIABETES CARE

The Management of Diabetic Neuropathy in CKD

(2009) Rodica Pop-Busui et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Subclinical Inflammation and Diabetic Polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany)

(2009) C. Herder et al.   DIABETES CARE